Laurus Labs Ltd. is a leading pharmaceutical company in India specializing in active pharmaceutical ingredients (API), Generic Finished dosage forms (FDF), and Contract Research services. With a focus on high-growth areas such as antiretrovirals, Hepatitis C, and Oncology, the company also produces APIs for various therapeutic areas like anti-asthma and cardiovascular health. Laurus Labs operates both in India and internationally, with a strong revenue stream from its overseas ventures. The company's ESG score is reflective of its commitment to sustainability and good governance practices.